A U.S. citizen working for a humanitarian organization in Congo has tested positive for the Ebola virus, the U.S. Centers for Disease Control and Prevention confirmed on Friday. The individual is currently receiving care while health officials work to identify close contacts and prevent further transmission.
The case comes as Congo struggles to contain what Africa Centres for Disease Control and Prevention officials describe as the fastest-growing Ebola outbreak ever recorded on the continent. The CDC said it was coordinating with the person's employer, other U.S. agencies, Congolese public health authorities and international partners in the response effort. No further details about the individual were released.
This is not the first American to contract the virus during the current outbreak. Earlier this week, an American doctor working in Congo tested positive for Ebola and was transferred to Germany for treatment.
The current outbreak is caused by the rare Bundibugyo strain of the virus, which has no approved vaccine or specific treatment. Congolese authorities declared a fresh outbreak on May 15 after the disease had been transmitting for weeks without official detection, according to the World Health Organization.
What the Left Is Saying
Democratic lawmakers and global health advocates have called for increased U.S. investment in the international response. Representative Ami Bera of California, who chairs the House Foreign Affairs Subcommittee on Oversight and Investigations, has previously argued that containing Ebola outbreaks abroad is directly tied to protecting Americans at home. "We cannot isolate ourselves from disease threats," he said during a 2024 hearing on pandemic preparedness. The Congressional Black Caucus has also pressed for additional humanitarian funding for Congo, citing the disproportionate impact of the outbreak on civilian populations in conflict-affected regions.
Organizations including Doctors Without Borders and the International Rescue Committee have urged wealthy nations to fund treatment trials and provide logistical support. "The lack of a proven vaccine or treatment for Bundibugyo makes this outbreak particularly dangerous," said Dr. Joanne Liu, international president of Doctors Without Borders, in a statement calling for accelerated research funding.
Humanitarian groups warn that attacks on health centers in eastern Congo are impeding response efforts. The IRC has documented at least 42 incidents affecting health workers since the outbreak began, with staff sometimes forced to flee active combat zones while treating patients.
What the Right Is Saying
Republican lawmakers have emphasized border security and domestic preparedness while expressing caution about extensive overseas commitments. Senator Joni Ernst of Iowa said the CDC should prioritize protecting Americans domestically rather than leading international response efforts. "Our focus needs to be ensuring proper screening protocols at ports of entry and working with allies on evacuation plans," she told reporters.
The Trump administration initially announced plans to send Americans exposed to Ebola in Congo to a new treatment facility in Kenya instead of repatriating them directly to the United States. However, those plans have been suspended following an order from a Kenyan court blocking the establishment of such a facility. Officials are now evaluating alternative arrangements for American citizens who may be infected during humanitarian work abroad.
Conservative commentators have questioned whether U.S. taxpayers should fund treatment centers in Africa when domestic health infrastructure needs resources. "We need to secure our own borders and ensure Americans have access to quality care before building hospitals overseas," wrote commentary at the National Review.
What the Numbers Show
The outbreak has reached 1,830 confirmed cases in Congo, including 648 deaths, according to the Africa Centres for Disease Control and Prevention as of this week. That represents a case fatality rate of approximately 35 percent.
Cases have also been confirmed in neighboring Uganda, raising concerns about cross-border transmission. The WHO has documented at least seven suspected cases in Uganda linked to contacts who traveled from Congo.
The Bundibugyo strain was first identified in 2007 and had not previously caused an outbreak of this scale. Previous Ebola outbreaks caused by the Zaire strain had mortality rates as high as 70 percent but benefited from established treatment protocols and experimental vaccines that do not exist for Bundibugyo.
Funding gaps have left response teams without sufficient resources. The WHO estimated in June that international donors had provided only 34 percent of the $87 million requested for the Congo Ebola response, leaving responders without critical supplies including protective equipment and laboratory capacity in remote areas.
The Bottom Line
The infection of a U.S. citizen highlights the ongoing risks faced by humanitarian workers responding to the outbreak while exposing gaps in America's strategy for managing citizens who contract dangerous diseases abroad. With no approved vaccine or treatment for Bundibugyo, officials face limited options for protecting both Americans overseas and preventing importation of cases.
The Kenyan court ruling blocking the planned treatment facility creates additional uncertainty. U.S. agencies must now identify alternative arrangements if more Americans are infected during humanitarian operations in Congo. Congress may face pressure to appropriate emergency funds for evacuation logistics or domestic treatment capacity.
What happens next will depend on whether the outbreak can be contained in eastern Congo, where ongoing conflict and attacks on health workers have hampered response efforts. International donors face decisions about funding levels for both immediate humanitarian needs and clinical trials that could eventually yield treatments for this strain.